USANA Health Sciences (USNA) Stock Overview
Develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
USNA Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
USANA Health Sciences, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$20.80 |
| 52 Week High | US$41.84 |
| 52 Week Low | US$18.70 |
| Beta | 0.60 |
| 1 Month Change | -27.09% |
| 3 Month Change | -33.84% |
| 1 Year Change | -43.49% |
| 3 Year Change | -62.35% |
| 5 Year Change | -72.51% |
| Change since IPO | 3,313.33% |
Recent News & Updates
USANA Health Sciences, Inc. (NYSE:USNA) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough
Oct 16
USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition
Oct 13Recent updates
USANA Health Sciences, Inc. (NYSE:USNA) Looks Inexpensive After Falling 31% But Perhaps Not Attractive Enough
Oct 16USANA Q3 2025 Preview: Short-Term Challenges Amid Strategic Transition
Oct 13Returns On Capital At USANA Health Sciences (NYSE:USNA) Paint A Concerning Picture
Oct 11USANA Health Sciences, Inc. (NYSE:USNA) Looks Inexpensive But Perhaps Not Attractive Enough
Jul 18Shareholders May Be Wary Of Increasing USANA Health Sciences, Inc.'s (NYSE:USNA) CEO Compensation Package
May 12The Market Doesn't Like What It Sees From USANA Health Sciences, Inc.'s (NYSE:USNA) Earnings Yet As Shares Tumble 25%
Apr 08There Are Reasons To Feel Uneasy About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Apr 04Should You Think About Buying USANA Health Sciences, Inc. (NYSE:USNA) Now?
Dec 09USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Sep 26
India Expansion And Decisive Acquisitions Promise Growth Amid Analyst Concerns Over Shrinking Margins
Expansion into India and strategic acquisitions offer significant growth opportunities for USANA, potentially boosting revenue and diversifying its market presence.Is There Now An Opportunity In USANA Health Sciences, Inc. (NYSE:USNA)?
Sep 08USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Jul 26There Is A Reason USANA Health Sciences, Inc.'s (NYSE:USNA) Price Is Undemanding
Jul 17USANA Health Sciences (NYSE:USNA) Might Be Having Difficulty Using Its Capital Effectively
May 29USANA Health Sciences, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
May 03Is Now The Time To Look At Buying USANA Health Sciences, Inc. (NYSE:USNA)?
May 01USANA Health Sciences, Inc.'s (NYSE:USNA) Prospects Need A Boost To Lift Shares
Apr 04USANA Health Sciences (NYSE:USNA) Could Be Struggling To Allocate Capital
Feb 08Is It Too Late To Consider Buying USANA Health Sciences, Inc. (NYSE:USNA)?
Jan 06USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation
Oct 23Are Investors Undervaluing USANA Health Sciences, Inc. (NYSE:USNA) By 22%?
Sep 09Here's What's Concerning About USANA Health Sciences' (NYSE:USNA) Returns On Capital
Jul 27Shareholder Returns
| USNA | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -0.4% | -2.0% | 2.0% |
| 1Y | -43.5% | -15.4% | 17.9% |
Return vs Industry: USNA underperformed the US Personal Products industry which returned -16% over the past year.
Return vs Market: USNA underperformed the US Market which returned 17.8% over the past year.
Price Volatility
| USNA volatility | |
|---|---|
| USNA Average Weekly Movement | 7.5% |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.4% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: USNA has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: USNA's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1992 | 1,700 | Jim Brown | www.usana.com |
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration.
USANA Health Sciences, Inc. Fundamentals Summary
| USNA fundamental statistics | |
|---|---|
| Market cap | US$380.05m |
| Earnings (TTM) | US$16.99m |
| Revenue (TTM) | US$912.67m |
Is USNA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| USNA income statement (TTM) | |
|---|---|
| Revenue | US$912.67m |
| Cost of Revenue | US$190.00m |
| Gross Profit | US$722.67m |
| Other Expenses | US$705.68m |
| Earnings | US$16.99m |
Last Reported Earnings
Sep 27, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.93 |
| Gross Margin | 79.18% |
| Net Profit Margin | 1.86% |
| Debt/Equity Ratio | 0% |
How did USNA perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/26 17:38 |
| End of Day Share Price | 2025/10/24 00:00 |
| Earnings | 2025/09/27 |
| Annual Earnings | 2024/12/28 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
USANA Health Sciences, Inc. is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Scott Van Winkle | Canaccord Genuity |
| John San Marco | Janney Montgomery Scott LLC |
| Stephanie Schiller Wissink | Jefferies LLC |